Volume 2 (2022) – Issue 3 – Cancer Diagnosis & Prognosis

By admin
0 Comments

Identification of Germline Mutations in Genes Involved in Classic FAP in Patients from Northern Brazil

DIEGO DI FELIPE ÁVILA ALCANTARA, SERGIO FIGUEIREDO LIMA JÚNIOR, PAULO PIMENTEL DE ASSUMPÇÃO, LETICIA MARTINS LAMARÃO, CARLA DE CASTRO SANT’ANNA, CAROLINE AQUINO MOREIRA-NUNES and ROMMEL RODRIGUEZ BURBANO

Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, Brazil, Molecular Biology Laboratory, Ophir Loyola Hospital, Belém, Brazil, Foundation Center for Hemotherapy and Hematology of Pará, Belém, Brazil, Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center, Federal University of Ceará, Fortaleza, Brazil

By admin
0 Comments

ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK–STAT3 Pathway

MELIKE DEMIR and ONUR CIZMECIOGLU

Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkeyna

By admin
0 Comments

CD103⁺ T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer

TAKUYA MORI, HIROAKI TANAKA, SOTA DEGUCHI, YUICHIRO MIKI, MAMI YOSHII, TATSURO TAMURA, TAKAHIRO TOYOKAWA, SHIGERU LEE, KAZUYA MUGURUMA and MASAICHI OHIRA

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan

By admin
0 Comments

Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases

KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, CHIAKI SUZUKI, HIROSHI KOTANI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, SHIGEKI NANJO, KANAME YAMASHITA, SHINJI TAKEUCHI and SEIJI YANO

Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Health Sciences, School of Medicine, University of Yamanashi, Chuo, Japan

By admin
0 Comments

Body Weight Change in Non-small Cell Lung Cancer Patients Treated With EGFR-TKI

TAKAHIDE KODAMA, SHINYA SATO, KUNIHIKO MIYAZAKI, SHINICHIRO OKAUCHI, YUIKA SASATANI, GEN OHARA, KATSUNORI KAGOHASHI, HIROAKI SATOH

Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital, Ryugasaki, Japan, Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Japan

By admin
0 Comments

Cytogenetic Biomonitoring in Buccal Mucosa Cells from Seaport Dockers

KATYANE NEGREIROS CAMPOS, MARIA ESTHER SUAREZ ALPIRE and DANIEL ARAKI RIBEIRO

Department of Biosciences, Institute of Health and Society, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

By admin
0 Comments

Total Risk Points Predict Short- and Long-term Outcomes Following Colorectal Cancer Resection in Older Patients

SHINTARO HASHIMOTO, KAZUO TO, HIDEO WADA, YUKA SAKAKIBARA, KEISUKE OZEKI, MICHIHIKO KOMAKI and MASAMICHI KONDO

Department of Surgery, National Hospital Organization Ureshino Medical Center, Ureshino, Japan, Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

By admin
0 Comments

Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience

HIROSHI YAEGASHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO, TOMOYUKI MAKINO, KANAME YAMASHITA, KOUSHIRO OHTSUBO, HIROKO IKEDA, ATSUSHI MIZOKAMI

Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan, Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan, Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Pathology, Kanazawa University Hospital, Kanazawa, Japan

By admin
0 Comments

Pre-operative Serum Albumin as a Potential Predictor of Benign Lesions in Renal Masses

SHO SEKITO, YUJI OGURA, NORIHITO SOGA and TAKAHIRO KOJIMA

Department of Urology, Aichi Cancer Center Hospital, Nagoya, Japan

By admin
0 Comments

Associations Between Plasma Concentrations of Lenvatinib and Angiopoietin and Clinical Responses to Lenvatinib Therapy in Japanese Patients With Thyroid Cancer

MAHO KUMAGAI, MITSUJI NAGAHAMA, YUMIKO AKAMINE, TOMOKO OZEKI, AKIFUMI SUZUKI, KIMINORI SUGINO, KOICHI ITO and MASATOMO MIURA

Department of Pharmacy, Akita University Hospital, Akita, Japan, Department of Surgery, Ito Hospital, Tokyo, Japan, Department of Pharmacokinetics, Akita University Graduate School of Medicine, Akita, Japan